US FDA approves Mesoblast cell therapy for graft-versus-host disease By Reuters
(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Mesoblast's (NASDAQ:) cell therapy to treat a type of ...
Tag: FDA
US FDA suspends Kezar Life Sciences lupus treatment trial after patient deaths By Reuters
(Reuters) -The US Food and Drug Administration has clinically suspended Kezar Life Sciences (NASDAQ:)' trial of an experimental lupus drug, ...
US FDA approves Zevra treatment for rare genetic disease By Reuters
(Reuters) - The U.S. Food and Drug Administration has approved Zevra Therapeutics' drug for a rare and fatal genetic disorder, ...
Abbott’s OTC glucose monitor is now available in the US
Healthcare technology company Abbott has been serving everyday consumers. Now, we can get one. The company just launched the Lingo ...
Zevra Gets FDA Administrative Committee Backing for Arimoclomol (NASDAQ:ZVRA)
JHVEPhoto A panel of independent advisors to the U.S. FDA voted in favor of a marketing application filed by Zevra ...
FDA approves new Alzheimer's drug: What you need to know
Transcription: CONWAY GITTENS: I'm Conway Gittens reporting from the New York Stock Exchange. Here's what we're watching today on TheStreet.stocks ...
Altria obtains FDA approval to market four electronic cigarette products
Mario Tama/Getty Images News The FDA announced on Friday that it has authorized the marketing of four Altria (New York ...
US FDA panel votes against Novo Nordisk's weekly insulin in patients with type 1 diabetes By Reuters
By Sriparna Roy and Mariam Sunny (Reuters) - Advisers to the U.S. health regulator voted on Friday against the use ...
OptiNose Stock Rises on FDA OK to Expand Xhance Labeling
Waldemarus OptiNose (NASDAQ: OPTN) shares gained in post-market trading on Friday after the company announced FDA approval of its application ...
FDA approves first over-the-counter continuous glucose monitor
The US Food and Drug Administration has approved the first continuous glucose monitor (CGM) that people can buy without a ...
Recommended.
